Parker Geoffrey M.'s Form 4 filing
Allogene Therapeutics, Inc. (ALLO) · filed Mar 6, 2024
- Accession no.
- 0001593968-24-000449
- Filed
- Mar 6, 2024
- Trade date
- Jan 30, 2024
- Filing delay
- 36 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $684. It was filed 36 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Parker Geoffrey M.CIK 0001491874 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2024 | Common Stock | PPurchaseAcquired | +190 | $3.60 | +$684 | 819,590 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.